MedPath

Effects of Melatonin on Cognitive Dysfunction After Electroconvulsive Therapy (ECT)

Phase 3
Conditions
Mood Disorders.
Mood [affective] disorders
F30-F39
Registration Number
IRCT2015103124793N1
Lead Sponsor
Anesthesiology Research Center, Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

affective disorders lead to hospitalization in psychiatric wards; age 18 to 65 years; having informed consent.

Exclusion criteria: substance abuse; schizophrenia; previous treatment with electroconvulsive therapy; having psychosis

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients' mental status. Timepoint: pretreatment, after finishing ECT sessions, 4 weeks after finishing all sessions. Method of measurement: Mini-mental Status Examination Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath